RCT

Pulmonary embolism (PE) management has seen significant advancements in recent years, with evolving guidelines, technological innovations, and emerging data reshaping clinical practice. This session will provide an in-depth look at the current landscape of PE treatment, focusing on key updates from IDE and RCT trial data, advancements in PE thrombectomy devices, and how the field is evolving in both academic and community settings.

We will begin by reviewing the latest data from pivotal trials, including IDE (Investigational Device Exemption) and randomized controlled trials (RCTs), which have driven much of the recent evolution in PE care. Speakers will examine the clinical impact of these studies on patient outcomes and explore areas where further research is still needed to define the optimal approach to PE treatment.

Next, we will explore the current state of PE thrombectomy technology, highlighting the latest devices and techniques that are changing the landscape of intervention. A detailed discussion on the efficacy, safety, and real-world performance of these devices will provide insight into their role in modern PE management.

The session will also delve into how the practice of PE management is evolving across different settings—academic medical centers and community hospitals alike. We will examine how institutions are adapting to these changes and what challenges remain in integrating cutting-edge therapies into diverse healthcare environments. This portion of the session will feature insights from thought leaders and frontline clinicians navigating these transitions.

To bring all this information to life, the session will feature a series of compelling, real-world cases with learning points designed to stimulate discussion. These cases will highlight the complexity of PE management, the decision-making process in thrombectomy, and unique patient scenarios that offer valuable takeaways for practitioners.

Learning Objectives:

1. Understand the impact of IDE and RCT trial data on the current standards of PE treatment.
2. Gain insight into the latest advancements in PE thrombectomy device technology.
3. Learn how PE management is evolving in both academic and community settings and the challenges of integrating new therapies.
4. Analyze real-world case studies to identify key learning points and apply evidence-based strategies in clinical practice.